According to a press release from Nutrasource, this is the first license to be obtained by a third-party, natural products-focused contract research organization in Canada. It will allow Nutrasource to possess and conduct activities including, but not limited to, holding, distributing, and conducting clinical research studies on controlled substances.
“With fully developed study protocols, safe storage and management as well as an experienced QPIC (Qualified Person in Charge) recognized by Health Canada’s Office of Controlled Substances, Nutrasource is ready for controlled drug and substances projects,” said Ana Samborski, Pharmacy Manager, Nutrasource.
Related: Nutrasource Announces Reception of Patent for IGEN Program The Natural View: Talking Certifications & Amazon Compliance Active Nutrition Conference Addresses Unmet Needs
This license will afford Nutrasource’s clients a unique opportunity to conduct early-stage clinical studies, including bioavailability/bioequivalence studies, proof-of-concept studies, and efficacy trials with controlled substances in Canada.William Rowe, Nutrasource President and CEO, said: “This license is an excellent and logical extension of ourInstitution-Wide Cannabis Research Licenseobtained earlier this year. Botanicals and their derivatives continue to be a key focus and these licenses enhance our position further in the nutra-to-pharma services pathway.”
